424 related articles for article (PubMed ID: 25065733)
1. HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation.
van Kempen PM; van Bockel L; Braunius WW; Moelans CB; van Olst M; de Jong R; Stegeman I; van Diest PJ; Grolman W; Willems SM
Cancer Med; 2014 Oct; 3(5):1185-96. PubMed ID: 25065733
[TBL] [Abstract][Full Text] [Related]
2. IGSF4 methylation as an independent marker of human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Chen KM; Stephen JK; Havard S; Mahan M; Divine G; Worsham MJ
JAMA Otolaryngol Head Neck Surg; 2015 Mar; 141(3):257-63. PubMed ID: 25569158
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation using 24-gene array in early head and neck cancer: better outcome in oral than in oropharyngeal cancer.
Noorlag R; van Kempen PM; Moelans CB; de Jong R; Blok LE; Koole R; Grolman W; van Diest PJ; van Es RJ; Willems SM
Epigenetics; 2014 Sep; 9(9):1220-7. PubMed ID: 25147921
[TBL] [Abstract][Full Text] [Related]
4. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
5. Frequent promoter hypermethylation associated with human papillomavirus infection in pharyngeal cancer.
Nakagawa T; Matsusaka K; Misawa K; Ota S; Takane K; Fukuyo M; Rahmutulla B; Shinohara KI; Kunii N; Sakurai D; Hanazawa T; Matsubara H; Nakatani Y; Okamoto Y; Kaneda A
Cancer Lett; 2017 Oct; 407():21-31. PubMed ID: 28823962
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
[TBL] [Abstract][Full Text] [Related]
7. Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma: a systematic review.
van Kempen PM; Noorlag R; Braunius WW; Stegeman I; Willems SM; Grolman W
Epigenetics; 2014 Feb; 9(2):194-203. PubMed ID: 24169583
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma.
van Kempen PM; Noorlag R; Braunius WW; Moelans CB; Rifi W; Savola S; Koole R; Grolman W; van Es RJ; Willems SM
Cancer Med; 2015 Oct; 4(10):1525-35. PubMed ID: 26194878
[TBL] [Abstract][Full Text] [Related]
9. HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas.
Kostareli E; Holzinger D; Bogatyrova O; Hielscher T; Wichmann G; Keck M; Lahrmann B; Grabe N; Flechtenmacher C; Schmidt CR; Seiwert T; Dyckhoff G; Dietz A; Höfler D; Pawlita M; Benner A; Bosch FX; Plinkert P; Plass C; Weichenhan D; Hess J
J Clin Invest; 2013 Jun; 123(6):2488-501. PubMed ID: 23635773
[TBL] [Abstract][Full Text] [Related]
10. DNA hypermethylation of
Birknerová N; Kovaříková H; Baranová I; Přikrylová A; Laco J; Vošmiková H; Gajdošová B; Hodek M; Vošmik M; Palička V; Chmelařová M
Epigenetics; 2022 Nov; 17(11):1301-1310. PubMed ID: 34974810
[TBL] [Abstract][Full Text] [Related]
11. Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
Ren S; Gaykalova D; Wang J; Guo T; Danilova L; Favorov A; Fertig E; Bishop J; Khan Z; Flam E; Wysocki PT; DeJong P; Ando M; Liu C; Sakai A; Fukusumi T; Haft S; Sadat S; Califano JA
Int J Cancer; 2018 Nov; 143(10):2425-2436. PubMed ID: 30070359
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic changes in the CDKN2A locus are associated with differential expression of P16INK4A and P14ARF in HPV-positive oropharyngeal squamous cell carcinoma.
Schlecht NF; Ben-Dayan M; Anayannis N; Lleras RA; Thomas C; Wang Y; Smith RV; Burk RD; Harris TM; Childs G; Ow TJ; Prystowsky MB; Belbin TJ
Cancer Med; 2015 Mar; 4(3):342-53. PubMed ID: 25619363
[TBL] [Abstract][Full Text] [Related]
13. Stratification of HPV-associated and HPV-negative oropharyngeal squamous cell carcinomas based on DNA methylation epigenotypes.
Nakagawa T; Matsusaka K; Misawa K; Ota S; Fukuyo M; Rahmutulla B; Kunii N; Sakurai D; Hanazawa T; Matsubara H; Okamoto Y; Kaneda A
Int J Cancer; 2020 May; 146(9):2460-2474. PubMed ID: 31997344
[TBL] [Abstract][Full Text] [Related]
14. High-risk HPV infection-associated hypermethylated genes in oropharyngeal squamous cell carcinomas.
Inokawa Y; Hayashi M; Begum S; Noordhuis MG; Sidransky D; Califano J; Koch W; Brait M; Westra WH; Hoque MO
BMC Cancer; 2022 Nov; 22(1):1146. PubMed ID: 36344942
[TBL] [Abstract][Full Text] [Related]
15. A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas.
Wang F; Zhang H; Xue Y; Wen J; Zhou J; Yang X; Wei J
Cancer Med; 2017 May; 6(5):910-917. PubMed ID: 28378539
[TBL] [Abstract][Full Text] [Related]
16. AKR1C3 is a biomarker and druggable target for oropharyngeal tumors.
Peraldo-Neia C; Ostano P; Mello-Grand M; Guana F; Gregnanin I; Boschi D; Oliaro-Bosso S; Pippione AC; Carenzo A; De Cecco L; Cavalieri S; Micali A; Perrone F; Averono G; Bagnasacco P; Dosdegani R; Masini L; Krengli M; Aluffi-Valletti P; Valente G; Chiorino G
Cell Oncol (Dordr); 2021 Apr; 44(2):357-372. PubMed ID: 33211282
[TBL] [Abstract][Full Text] [Related]
17. Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated disease.
Bartemes KR; Gochanour BR; Routman DM; Ma DJ; Doering KA; Burger KN; Foote PH; Taylor WR; Mahoney DW; Berger CK; Cao X; Then SS; Haller TJ; Larish AM; Moore EJ; Garcia JJ; Graham RP; Bakkum-Gamez JN; Kisiel JB; Van Abel KM
Oral Oncol; 2023 Nov; 146():106568. PubMed ID: 37717549
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic Mechanisms of Human Papillomavirus-Associated Head and Neck Cancer.
Anayannis NV; Schlecht NF; Belbin TJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1373-8. PubMed ID: 25978766
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus genotype and oropharynx cancer survival in the United States of America.
Goodman MT; Saraiya M; Thompson TD; Steinau M; Hernandez BY; Lynch CF; Lyu CW; Wilkinson EJ; Tucker T; Copeland G; Peters ES; Altekruse S; Unger ER
Eur J Cancer; 2015 Dec; 51(18):2759-67. PubMed ID: 26602016
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]